P854: HEXABODY-CD38 INDUCES TROGOCYTOSIS AND EFFECTIVELY INDUCES COMPLEMENT-MEDIATED TUMOR CELL LYSIS AFTER TREATMENT WITH DARATUMUMAB OR ISATUXIMAB IN VITRO

por Hiemstra, I. H., Santegoets, K., Janmaat, M. L., Ten Hagen, W., Van Dooremalen, S., De Goeij, B. E., Bosgra, S., Sasser, A. K., Breij, E. C.
Publicado 2022